Multifocal Motor Neuropathy with Conduction Block: Current Issues in Diagnosis and Treatment

Smriti V. Nagale, E. Peter Bosch

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Multifocal motor neuropathy (MMN) with conduction block is an acquired, autoimmune-mediated neuropathy that is responsive to treatment. The clinical history is one of slowly, progressive distal weakness, which more commonly involves the upper extremities, and it affects mainly young adults. Physical examination reveals weakness without sensory loss in the distribution of individual nerves. Atrophy may be present, but hyperreflexia and spasticity are not seen. Electrophysiological studies reveal motor conduction blocks at sites not prone to compression with normal sensory responses. Immunoglobulin M anti-GM1 titers may be elevated. Treatment with human immunoglobulin or cyclophosphamide has been shown to improve strength in the majority of patients with MMN in the short term. However, motor strength and function may gradually decline over years in spite of long-term therapy.

Original languageEnglish (US)
Pages (from-to)325-333
Number of pages9
JournalSeminars in Neurology
Volume23
Issue number3
DOIs
StatePublished - Sep 2003

Fingerprint

Abnormal Reflexes
Upper Extremity
Cyclophosphamide
Physical Examination
Atrophy
Immunoglobulin M
Immunoglobulins
Young Adult
Therapeutics

Keywords

  • Diagnosis
  • Multifocal motor neuropathy with conduction block
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Multifocal Motor Neuropathy with Conduction Block : Current Issues in Diagnosis and Treatment. / Nagale, Smriti V.; Bosch, E. Peter.

In: Seminars in Neurology, Vol. 23, No. 3, 09.2003, p. 325-333.

Research output: Contribution to journalArticle

Nagale, Smriti V. ; Bosch, E. Peter. / Multifocal Motor Neuropathy with Conduction Block : Current Issues in Diagnosis and Treatment. In: Seminars in Neurology. 2003 ; Vol. 23, No. 3. pp. 325-333.
@article{aa7e16dc2a764bdcb6b3bbe1ded8acbd,
title = "Multifocal Motor Neuropathy with Conduction Block: Current Issues in Diagnosis and Treatment",
abstract = "Multifocal motor neuropathy (MMN) with conduction block is an acquired, autoimmune-mediated neuropathy that is responsive to treatment. The clinical history is one of slowly, progressive distal weakness, which more commonly involves the upper extremities, and it affects mainly young adults. Physical examination reveals weakness without sensory loss in the distribution of individual nerves. Atrophy may be present, but hyperreflexia and spasticity are not seen. Electrophysiological studies reveal motor conduction blocks at sites not prone to compression with normal sensory responses. Immunoglobulin M anti-GM1 titers may be elevated. Treatment with human immunoglobulin or cyclophosphamide has been shown to improve strength in the majority of patients with MMN in the short term. However, motor strength and function may gradually decline over years in spite of long-term therapy.",
keywords = "Diagnosis, Multifocal motor neuropathy with conduction block, Treatment",
author = "Nagale, {Smriti V.} and Bosch, {E. Peter}",
year = "2003",
month = "9",
doi = "10.1055/s-2003-814745",
language = "English (US)",
volume = "23",
pages = "325--333",
journal = "Seminars in Neurology",
issn = "0271-8235",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Multifocal Motor Neuropathy with Conduction Block

T2 - Current Issues in Diagnosis and Treatment

AU - Nagale, Smriti V.

AU - Bosch, E. Peter

PY - 2003/9

Y1 - 2003/9

N2 - Multifocal motor neuropathy (MMN) with conduction block is an acquired, autoimmune-mediated neuropathy that is responsive to treatment. The clinical history is one of slowly, progressive distal weakness, which more commonly involves the upper extremities, and it affects mainly young adults. Physical examination reveals weakness without sensory loss in the distribution of individual nerves. Atrophy may be present, but hyperreflexia and spasticity are not seen. Electrophysiological studies reveal motor conduction blocks at sites not prone to compression with normal sensory responses. Immunoglobulin M anti-GM1 titers may be elevated. Treatment with human immunoglobulin or cyclophosphamide has been shown to improve strength in the majority of patients with MMN in the short term. However, motor strength and function may gradually decline over years in spite of long-term therapy.

AB - Multifocal motor neuropathy (MMN) with conduction block is an acquired, autoimmune-mediated neuropathy that is responsive to treatment. The clinical history is one of slowly, progressive distal weakness, which more commonly involves the upper extremities, and it affects mainly young adults. Physical examination reveals weakness without sensory loss in the distribution of individual nerves. Atrophy may be present, but hyperreflexia and spasticity are not seen. Electrophysiological studies reveal motor conduction blocks at sites not prone to compression with normal sensory responses. Immunoglobulin M anti-GM1 titers may be elevated. Treatment with human immunoglobulin or cyclophosphamide has been shown to improve strength in the majority of patients with MMN in the short term. However, motor strength and function may gradually decline over years in spite of long-term therapy.

KW - Diagnosis

KW - Multifocal motor neuropathy with conduction block

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0346847756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346847756&partnerID=8YFLogxK

U2 - 10.1055/s-2003-814745

DO - 10.1055/s-2003-814745

M3 - Article

C2 - 14722828

AN - SCOPUS:0346847756

VL - 23

SP - 325

EP - 333

JO - Seminars in Neurology

JF - Seminars in Neurology

SN - 0271-8235

IS - 3

ER -